title: LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins.
abstract: LKB1 plays the role of tumor suppressor, opposite to Akt, by negatively regulating mammalian target of rapamycin through the activation of AMP-activated protein kinase and TSC signaling. We have discovered a novel, potentially oncogenic role for LKB1 as a supporter of Akt-mediated phosphorylation of proapoptotic proteins. We found that Akt activation led to increased phosphorylation of FoxO3a at Thr(32) in LKB1 wild-type cells but not in LKB1-null cells. Depletion of LKB1 in the cells with wild-type LKB1 resulted in attenuation of that phosphorylation of FoxO3a by activated Akt, whereas the restoration of LKB1 function in LKB1-null cells reestablished Akt-mediated FoxO3a phosphorylation. On expanding our analysis to other Akt targets, using isogenic LKB1 knockdown cell line pairs and a phospho-specific antibody microarray, we observed that there was a requirement for LKB1 in the phosphorylation of other Akt downstream targets, including Ask1 (Ser(83)), Bad (Ser(136)), FoxO1 (Ser(319)), FoxO4 (Ser(197)), and glycogen synthase kinase 3beta (GSK3beta; Ser(9)). Because the phosphorylation of these sites by Akt suppresses apoptosis, the requirement of LKB1 suggests that LKB1 may have an antiapoptotic role in tumor cells with constitutively active Akt. Indeed, we found that the suppression of LKB1 expression led to apoptosis in three cell lines in which Akt is constitutively active but not in two cell lines without Akt activation. This observation may explain the lack of LKB1 somatic mutations in brain, breast, and colon cancers, where Akt is frequently activated due to mutations in phosphatidylinositol 3-kinase, PTEN, or Akt itself.
authors.affiliation: The Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
authors.forename: Diansheng
authors.initials: D
authors.lastname: Zhong
authors.forename: Xiuju
authors.initials: X
authors.lastname: Liu
authors.forename: Fadlo R
authors.initials: FR
authors.lastname: Khuri
authors.forename: Shi-Yong
authors.initials: SY
authors.lastname: Sun
authors.forename: Paula M
authors.initials: PM
authors.lastname: Vertino
authors.forename: Wei
authors.initials: W
authors.lastname: Zhou
mesh_terms: D000091162:AMP-Activated Protein Kinase Kinases; D017209:Apoptosis / Q000502:physiology; D002289:Carcinoma, Non-Small-Cell Lung / Q000201:enzymology / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D053148:Caspase 3 / Q000378:metabolism; D048708:Cell Growth Processes / Q000502:physiology; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000201:enzymology / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D016193:G1 Phase / Q000502:physiology; D045325:HCT116 Cells; D006801:Humans; D008175:Lung Neoplasms / Q000201:enzymology / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000235:genetics; D015398:Signal Transduction; D014162:Transfection
chemical_list: C499517:FOXO3 protein, human; D000071316:Forkhead Box Protein O3; D051858:Forkhead Transcription Factors; D034741:RNA, Small Interfering; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt; C109790:STK11 protein, human; D000091162:AMP-Activated Protein Kinase Kinases; D053148:Caspase 3
references.citation: Nat Rev Cancer. 2002 Jul;2(7):529-35
references.pmid: 12094239
references.citation: Mol Cell. 2004 May 21;14(4):416-8
references.pmid: 15149589
references.citation: J Cell Biol. 2003 Aug 18;162(4):613-22
references.pmid: 12913110
references.citation: Nature. 2002 Sep 12;419(6903):162-7
references.pmid: 12226664
references.citation: Cancer Cell. 2004 Jul;6(1):91-9
references.pmid: 15261145
references.citation: Cancer Res. 1998 May 15;58(10):2087-90
references.pmid: 9605748
references.citation: Oncogene. 2005 Nov 14;24(50):7455-64
references.pmid: 16288292
references.citation: Mol Cell. 2001 Jun;7(6):1307-19
references.pmid: 11430832
references.citation: J Biol. 2003;2(4):28
references.pmid: 14511394
references.citation: Nat Cell Biol. 2003 Oct;5(10):889-94
references.pmid: 12973359
references.citation: Cancer Res. 2002 Jul 1;62(13):3659-62
references.pmid: 12097271
references.citation: Cancer Res. 2006 Nov 15;66(22):10701-8
references.pmid: 17108107
references.citation: Cancer Cell. 2002 Jul;2(1):81-91
references.pmid: 12150827
references.citation: Genes Dev. 2002 Apr 15;16(8):984-93
references.pmid: 11959846
references.citation: Biochem J. 2004 Jun 1;380(Pt 2):297-309
references.pmid: 15005655
references.citation: Lung Cancer. 2006 Sep;53(3):285-94
references.pmid: 16822578
references.citation: Mol Cell Biol. 2007 Nov;27(21):7405-13
references.pmid: 17724079
references.citation: Clin Genet. 2000 May;57(5):394-7
references.pmid: 10852375
references.citation: J Biol Chem. 2005 Apr 15;280(15):15158-64
references.pmid: 15713674
references.citation: Trends Biochem Sci. 2002 Jul;27(7):352-60
references.pmid: 12114024
references.citation: Am J Pathol. 1999 Mar;154(3):677-81
references.pmid: 10079245
references.citation: EMBO J. 2004 Feb 25;23(4):833-43
references.pmid: 14976552
references.citation: Cancer Res. 1998 Apr 1;58(7):1384-6
references.pmid: 9537235
references.citation: Oncogene. 2005 Feb 17;24(8):1477-80
references.pmid: 15608678
references.citation: Nature. 2007 Aug 16;448(7155):807-10
references.pmid: 17676035
references.citation: Genes Dev. 2004 Jul 1;18(13):1533-8
references.pmid: 15231735
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9248-51
references.pmid: 10430928
references.citation: Oncogene. 1998 Sep 24;17(12):1557-65
references.pmid: 9794233
references.citation: Nature. 1998 Jan 8;391(6663):184-7
references.pmid: 9428765
references.citation: Science. 2004 Apr 23;304(5670):554
references.pmid: 15016963
references.citation: Hum Mutat. 2005 Oct;26(4):291-7
references.pmid: 16110486
references.citation: Semin Cell Dev Biol. 2004 Apr;15(2):171-6
references.pmid: 15209376
references.citation: J Neurooncol. 2000 Sep;49(3):187-95
references.pmid: 11212897
references.citation: Curr Biol. 2003 Nov 11;13(22):2004-8
references.pmid: 14614828
references.citation: Clin Cancer Res. 2006 Dec 1;12(23):7117-25
references.pmid: 17145836
references.citation: Oncogene. 1998 Jul 30;17(4):475-9
references.pmid: 9696041
references.citation: J Virol. 2005 Dec;79(23):14507-15
references.pmid: 16282450
references.citation: Mol Cancer Ther. 2008 Apr;7(4):809-17
references.pmid: 18413794